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Six strains of a previously undescribed catalase-positive coryneform bacterium isolated from clinical spec-
imens from dogs were characterized by phenotypic and molecular genetic methods. Biochemical and chemo-
taxonomic studies revealed that the unknown bacterium belonged to the genus Corynebacterium sensu stricto.
Comparative 16S rRNA gene sequencing showed that the six strains were genealogically highly related and
constitute a new subline within the genus Corynebacterium; this subline is close to but distinct from C. falsenii,
C. jeikeium, and C. urealyticum. The unknown bacterium from dogs was distinguished from all currently
validated Corynebacterium species by phenotypic tests including electrophoretic analysis of whole-cell proteins.
On the basis of phylogenetic and phenotypic evidence, it is proposed that the unknown bacterium be classified
as a new species, Corynebacterium auriscanis. The type strain of C. auriscanis is CCUG 39938T.
The genus Corynebacterium contains many species which
have long been recognized as pathogens of humans and/or
animals. During the past two decades, the taxonomy of this
important group of organisms has undergone dramatic change.
In particular, the use of molecular chemical and molecular
genetic methodologies has facilitated a much tighter circum-
scription of the genus, and the availability of comparative 16S
rRNA gene sequence data combined with improved pheno-
typic data has resulted in much improved and more reliable
species identification. These improvements in taxonomy and
diagnostics, together with an increased interest in corynebac-
teria as opportunistic pathogens of humans, has resulted in the
delineation of a plethora of new Corynebacterium species from
human sources in recent years (see reference 14 for a review).
Indeed, since 1990, over 20 new species that cause and/or that
are associated with human disease have been described (see
reference 14 for species identified prior to 1996 and previous
reports for C. confusum [12], C. coyleae [13], C. durum [20], C.
falsenii [24], C. imitans [8], C. kroppenstedtii [4], C. lipophilofla-
vum [9], C. mucifaciens [10], C. singulare [21], C. sundsvallense
[3], C. riegelii [11], C. thomssenii [25]). The association of
corynebacteria with animal disease has received much less
attention, although there are indications (6, 7) that the imple-
mentation of improved diagnostic methods will result in a
better understanding of the range of corynebacterial species
involved in animal disease and in the recognition of new di-
versity. In this article we report on the polyphasic character-
ization (by use of phenotypic and molecular genetic techniques
in concert) of six coryneform-like isolates that originated from
clinical specimens from dogs. On the basis of the findings of
this study, a new species, Corynebacterium auriscanis, is de-
scribed.
MATERIALS AND METHODS
Cultures and cultivation. Three of the six strains examined were isolated from
specimens that originated from dogs with ear infections: strain M598/96/1 was
recovered in mixed culture with Staphylococcus intermedius and Streptococcus
canis from a dog suffering from bilateral otitis; strain M135/96/2 was obtained
along with a Staphylococcus sp. and a Proteus sp. from a dog suffering from
chronic otitis externa with a purulent discharge; strain M1426/97/3 was also
recovered in mixed culture (with Malassezia pachydermatis, Streptococcus canis,
and Staphylococcus intermedius) from the ear of a dog suffering from chronic
pustular otitis externa. Strain M2813/97/1 was the sole isolate obtained from a
dog with a deep pyoderma, whereas strain M210/98/3 was recovered from a
polymicrobic infection of a dog with an interdigital cyst. Isolate M2555/95/2 was
obtained from a vaginal swab together with Streptococcus canis and Staphylococ-
cus intermedius. Strains M598/96/1, M135/96/2, M1426/97/3, M2813/97/1, and
M210/98/3 have been deposited in the Culture Collection of the University of
Goteborg (CCUG) under accession nos. CCUG 39938T, CCUG 39940, CCUG
39941, CCUG 39784, and CCUG 39783, respectively. All strains were cultured
on Columbia agar (Difco, Detroit, Mich.) supplemented with 5% defibrinated
horse blood (Oxoid, Unipath Ltd., Basingstoke, United Kingdom) at 37°C in air
plus 5% CO2.
Phenotypic characterization. The strains were biochemically characterized by
using the API Coryne system (API bioMe´rieux, Marcy l’Etoile, France). Enzyme
reactions were read after 24 h of incubation at 37°C, whereas acid production
from carbohydrates was observed after 48 h. Further enzyme reactions were
studied by means of the API ZYM system. Polyacrylamide gel electrophoretic
(PAGE) analysis of whole-cell proteins was performed as described by Pot et al.
(19). For densitometric analysis and normalization and interpretation of protein
patterns, the GelCompar GCW 3.0 software package (Applied Maths, Kortrijk,
Belgium) was used. The similarity between all pairs of traces was expressed by
the Pearson product moment correlation coefficient converted for convenience
to a percent similarity value. Cell wall murein was prepared by mechanical
disruption of cells with a Braun homogenizer, and complete acid hydrolysates (4
M HCl) were analyzed as described by Schleifer and Kandler (23). Fatty acid
methyl esters were prepared and analyzed as described by Kampfer and Krop-
penstedt (16). Mycolic acid composition was determined by the methods of
Minnikin et al. (18) and Klatte et al. (17). The G1C content of DNA was
determined by thermal denaturation (15).
Phylogenetic characterization. Phylogenetic analysis was conducted by 16S
rRNA gene sequence analysis. A large fragment of the 16S rRNA gene was
amplified by PCR with universal primers pA and pH* (2), close to the 39 and 59
ends of the gene, respectively, and was directly sequenced with a Taq dye-Deoxy
terminator cycle sequencing kit (Applied Biosystems, Foster City, Calif.) and an
automatic DNA sequencer (model 373A; Applied Biosystems). The closest
known relatives of the new isolates were determined by performing database
searches. These sequences and those of other known related strains were re-
trieved from the GenBank or Ribosomal Database Project (RDP) Libraries and
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were aligned with the newly determined sequence by using the program
PILEUP. The resulting multiple sequence alignment was corrected manually,
and a distance matrix was calculated by using the programs PRETTY and
DNADIST (with the Kimura-2 correction parameter) (5). A phylogenetic tree
was constructed by the neighbor-joining method (22) with the program NEIGH-
BOR (5), and the stability of the groupings was estimated by bootstrap analysis
(500 replications) with the programs DNABOOT, DNADIST, NEIGHBOR,
and CONSENSE (5).
Nucleotide sequence accession number. The 16S rRNA gene sequence of
strain CCUG 39938T has been deposited in GenBank under accession no.
AJ23851.
RESULTS AND DISCUSSION
The six isolates obtained from clinical specimens from dogs
consisted of gram-positive, nonmotile, short, club-shaped rods
which occurred as single cells, in pairs, or in small clusters. The
strains were catalase positive and did not require lipid supple-
mentation for optimal growth. The isolates produced acid from
glucose but not from the other carbohydrates examined. They
hydrolyzed hippurate but not gelatin, starch, or urea. Esculin
hydrolysis was variable. The strains displayed acid phospha-
tase, alkaline phosphatase, ester lipase C8 (weak reaction),
esterase C4 (weak reaction), leucine arylamidase, phosphoami-
dase, and pyrrolidonyl arylamidase activity. They were pyrazi-
namidase negative and did not reduce nitrate to nitrite. On the
basis of their cellular morphologies and biochemical profiling,
the isolates from dogs resembled corynebacteria, although
their reactions did not conform to those for any currently
recognized species. To ascertain whether or not the unidenti-
FIG. 1. Similarity dendrogram based on whole-cell protein pattern of C. auriscanis sp. nov. and related species. Levels of correlation are expressed as percentages
of similarity for convenience.
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fied bacterium was a member of the genus Corynebacterium,
the cell wall murein structure and lipid composition of a rep-
resentative strain, strain CCUG 39938T, were determined.
Analysis of the cell wall amino acid composition revealed
meso-diaminopimelic acid (meso-Dpm) as the dibasic acid, to-
gether with alanine and glutamic acid, consistent with a type
A1 g directly cross-linked murein. Thin-layer chromatographic
analysis of whole-organism acid methanolysates demonstrated
FIG. 2. Unrooted tree showing the phylogenetic relationships of C. auriscanis sp. nov. and members of the genus Corynebacterium. The tree was constructed by the
neighbor-joining method and was based on a comparison of approximately 1,320 nucleotides. Bootstrap values, expressed as a percentage of 500 replications, are given
at branching points. Bar, 1% sequence divergence.
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the presence of short-chain mycolic acids within the bacterium.
High-temperature gas-liquid chromatographic analysis of tri-
methylsilylated derivatives revealed C28 to C34 mycolic acids,
with C32:0 predominating. Analysis of nonhydroxylated cellular
fatty acids showed the presence of solely straight-chain satu-
rated and monounsaturated types, with C16:0 (37%) and C18:
1v9c (51%) as the major acids. Tuberculostearic acid was not
present. These chemical findings unequivocally demonstrate
that strain CCUG 39938T is a member of the genus Coryne-
bacterium. The whole-cell protein profiles of five strains
(strains CCUG 39938T, CCUG 39940, CCUG 39941, CCUG
39783, and CCUG 39784) were examined by sodium dodecyl
sulfate-PAGE and were compared with those of known
Corynebacterium species. A dendrogram derived from a nu-
merical analysis of protein patterns is shown in Fig. 1. The
isolates were found to be phenotypically highly related and
formed a robust cluster (grouping at the correlation level of
greater than 80%) which was separate from all other coryne-
bacteria examined. To determine the phylogenetic relation-
ships of the unknown bacterium from dogs, the almost com-
plete 16S rRNA gene sequence (1,452 bases) of a
representative strain (strain CCUG 39938T) was determined.
Sequence searches of the GenBank and RDP libraries re-
vealed that the newly determined sequence was phylogeneti-
cally highly related to those of species of the genus Corynebac-
terium (data not shown), with C. falsenii, C. jeikeium, and C.
urealyticum displaying the highest level of sequence relatedness
(97, 96.5, and 96.2% sequence similarity, respectively). A tree,
constructed by the neighbor-joining method, that incorporates
the unknown bacterium (as exemplified by strain CCUG
39938T) and all currently described Corynebacterium species, is
shown in Fig. 2. The unidentified bacterium formed a distinct
subline that was close to albeit distinct from C. falsenii, C.
jeikeium, and C. urealyticum. Partial 16S rRNA gene sequenc-
ing (approximately 800 bases) was performed with the other
five clinical isolates, and they were found to be highly related
to strain CCUG 39938T (99.9 to 100% sequence similarity).
It is evident from the comparative 16S rRNA sequence anal-
ysis that the six isolates from clinical specimens from dogs are
members of a hitherto unknown Corynebacterium species. Phy-
logenetically, the bacterium is closely related to C. falsenii, C.
jeikeium, and C. urealyticum, although 16S rRNA divergence
values of approximately 3% clearly demonstrate that it merits
separate species status. PAGE analysis of whole-cell proteins
and biochemical profiling also showed that the bacterium from
dogs is distinct from the aforementioned species and all other
reference corynebacteria examined. In particular, the unknown
bacterium could be readily distinguished from its closest phy-
logenetic relatives, C. falsenii, C. jeikeium, and C. urealyticum,
by its production of pyrrolidonyl aryamidase and its failure to
produce pyrazinamidase. Additionally, the bacterium differs
markedly from C. jeikeium and C. urealyticum in that it is
nonlipophilic, and it can be further distinguished from C. false-
nii and C. urealyticum in that it does not hydrolyze urea. Tests
which are useful in differentiating the unknown bacterium
from dogs from other nonlipophilic Corynebacterium species
are shown in Table 1. It is pertinent to note that the novel
bacterium from dogs can also be readily distinguished from
other nonlipophilic coryneform genera, such as Arthrobacter,
Aureobacterium, Cellulomonas, Curtobacterium, Exiguobacte-
rium, and Microbacterium, in that it possesses mycolic acids,
predominantly straight-chain and monounsaturated cellular
fatty acids, and meso-Dpm in its cell wall. By contrast, the
coryneform taxa mentioned above invariably lack mycolic ac-
ids, possess high levels of methyl branched-chain cellular fatty
acids, and contain cell walls based on lysine and/or ornithine
(14). Therefore, on the basis of the results of the polyphasic
taxonomic investigation, we propose that the bacterium from
dogs be classified as a new species, Corynebacterium auriscanis.
Description of Corynebacterium auriscanis sp. nov. Coryne-
bacterium auriscanis (au.ris.canis. L. fem. n. auris ear; L. masc.
n. canis dog; M.L. gen. n. auriscanis of the ear of the dog).
Cells are gram positive, non-spore forming, and nonmotile.
They are typically club-shaped rods, which appear as single
cells, in pairs, or in clusters. The cells are nonfermentative and
grow under aerobic conditions but not under anaerobic con-
ditions. The cells are CAMP reaction negative. The cells are
catalase positive and nonlipophilic. Acid is produced from
glucose but not from glycogen, lactose, maltose, mannitol, su-
crose, ribose, or D-xylose. Hippurate is hydrolyzed. Esculin
hydrolysis is variable. Gelatin and starch are not hydrolyzed.
Nitrate is not reduced, and the Voges-Proskauer test is nega-
tive. Acid phosphatase, alkaline phosphatase, ester lipase C8
(weak reaction), esterase C4 (weak reaction), leucine arylami-
TABLE 1. Characteristics useful in differentiating C. auriscanis from some other nonlipophilic Corynebacterium speciesa
Organism Nitratereduction
Urease
hydrolysis
Aesculin
hydrolysis
Pyrizinamidase
reaction
Alkaline
phophatase
Acid produced from: CAMP
reaction
Myocolic
acid
productionGlucose Maltose Sucrose
C. auriscanis 2 2 V 2 1 1 2 2 2 1
C. confusum 1 2 2 1 1 (1) 2 2 2 1
C. falsenii 2 (1) 2 W 1 (1) (V) 2 2 1
C. amycolatum V V 2 1 1 1 V V 2 2
C. argentoratense 2 2 2 1 V 1 2 2 2 1
C. coyleae 2 2 2 1 1 (1) 2 2 1 1
C. diphtheriae V 2 2 2 2 1 1 2 2 1
C. durum 1 (V) (V) 2 2 1 1 1 2 1
C. glucuronolyticum V V V 1 V 1 V 1 1 1
C. imitans 2 2 2 W 1 1 1 W 1 1
C. matruchotii 1 1 1 1 2 1 1 1 2 1
C. minutissimum 2 2 2 1 1 1 1 V 2 1
C. pseudotuberculosis 2 1 2 2 V 1 1 V REV 1
C. striatum 1 2 2 1 1 1 2 V V 1
C. ulcerans 2 1 2 2 1 1 1 2 REV 1
C. xerosis V 2 2 1 1 1 1 1 2 1
a Data are from references 1, 5, 6, 11, 12 and 13 and the present study. Symbols and abbreviations: parentheses, delayed reaction; W, weakly positive; V, variable;
REV, reverse.
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dase, phosphoamidase, and pyrrolidonyl arylamidase activities
are detected. N-Acetylglucosaminidase, chymotrypsin, cystine
arylamidase, a-fucosidase, a-galactosidase, b-galactosidase,
a-glucosidase, b-glucosidase, b-glucuronidase, a-mannosidase,
pyrazinamidase, trypsin, urease, and valine arylamidase activ-
ities are not detected. Lipase C14 activity is variable. The cell
wall contains meso-Dpm as the dibasic amino acid. Short-chain
mycolic acids (C28 to C34) are present, with C30:0, C32:0, and
C34:0 as the main components. The long-chain fatty acids are of
the saturated straight-chain and monounsaturated types, with
C16:0 and C18:v9c predominating. Tuberculostearic acid is not
present. The G1C content of DNA is 61 mol%. The organism
was isolated from clinical specimens from dogs. Its habitat is
not known. The type strain is CCUG 39938T.
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